Immutep Limited Cash Flow Conversion Efficiency

Latest as of June 2023: -0.086x

Immutep Limited cash flow conversion efficiency. Based on the latest financial reports, Immutep Limited (YP1A) has a cash flow conversion efficiency ratio of -0.086x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-11.72 Million ≈ $-13.70 Million USD) by net assets (€136.47 Million ≈ $159.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Immutep Limited (2017–2023)

Cash flow conversion efficiency of Immutep Limited from 2017 to 2023. This chart illustrates how Immutep Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Immutep Limited stock price for real-time trading data and today's change.

Immutep Limited Cash Flow Conversion Ratio Explained

Immutep Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Immutep Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Immutep Limited ranked by their cash flow conversion efficiency. Also see YP1A company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Iskandar Waterfront City Bhd KLSE:1589	0.015x
Beijing JIAYU Door Window Curtain SHE:300117	-0.023x
DMS Propertindo Tbk PT JK:KOTA	-0.003x
Walkabout Resources Ltd AU:WKT	-0.073x
PEH Wertpapier AG F:PEH	0.048x
Green Cross Medical Science Corporation KQ:142280	-0.013x
Waskita Beton Precast Tbk PT JK:WSBP	0.008x
Dongbang Agro KO:007590	-0.158x

Annual Cash Flow Conversion Efficiency for Immutep Limited (2017–2023)

The table below shows the annual cash flow conversion efficiency of Immutep Limited from 2017 to 2023. Review YP1A financial flexibility score to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-06-30	€136.47 Million ≈ $159.55 Million	€-35.36 Million ≈ $-41.33 Million	-0.259x	-17.20%
2022-06-30	€136.76 Million ≈ $159.88 Million	€-30.23 Million ≈ $-35.34 Million	-0.221x	+8.19%
2021-06-30	€73.27 Million ≈ $85.66 Million	€-17.64 Million ≈ $-20.62 Million	-0.241x	+26.04%
2020-06-30	€33.30 Million ≈ $38.93 Million	€-10.84 Million ≈ $-12.67 Million	-0.326x	+48.07%
2019-06-30	€24.39 Million ≈ $28.51 Million	€-15.29 Million ≈ $-17.87 Million	-0.627x	-170.19%
2018-06-30	€33.52 Million ≈ $39.19 Million	€-7.78 Million ≈ $-9.09 Million	-0.232x	+27.64%
2017-06-30	€26.53 Million ≈ $31.02 Million	€-8.51 Million ≈ $-9.95 Million	-0.321x	--

About Immutep Limited

F:YP1A Germany Biotechnology

Market Cap

$475.53 Million

€406.75 Million EUR

Market Cap Rank

#22118 Global

#1947 in Germany

Share Price

€2.76

Change (1 day)

-2.13%

52-Week Range

€0.21 - €4.05

All Time High

€4.52